| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000028522 |
| Receipt No. | R000032645 |
| Official scientific title of the study | A clinical study for evaluating the safety of excessive consumption of corn germ extract (glucosylceramide fraction) |
| Date of disclosure of the study information | 2017/08/03 |
| Last modified on | 2017/08/03 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | A clinical study for evaluating the safety of excessive consumption of corn germ extract (glucosylceramide fraction) | |
| Title of the study (Brief title) | A clinical study for evaluating the safety of excessive consumption of corn germ extract | |
| Region |
|
|
| Condition | ||
| Condition | not for special condition | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The purpose of this study is to evaluate the safety of overdose ceramide |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The number of the adverse event which have the causal relationship between the test food observed during test period |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | One capsule (10 mg of glucosylceramide ) a day | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)20<=age<=60
2)Male and female 3)Outpatients 4)Healthy adults 5)Those with normal blood test results (or evaluated by the primary investigator). 6)Those who are able to take the test food for a month 7)Those who keep daily lifestyle during the test period 8)Those who are able to consent by the document 9)Those who are not correspond to the exclusion criteria |
|||
| Key exclusion criteria | 1)Those who are with a history of treatment such as myocardial infarction or heart failure
2)Exclusion for diseases (atrial fibrillation, arrhythmia, liver failure, renal failure, cerebrovascular disease, arthritis, diabetes, dyslipidemia, those being treated with high blood pressure, and other chronic diseases, etc.) 3)Who are corresponding the criteria D of the scale of health screening Society 4)Those who take any drugs and supplements (including herbal medicine) 5)Those who are allergic (pharmaceuticals and test article-related food) 6)Those who are Pregnancy or lactation, or to be expected pregnant during the study period 7)Those who are participating in other clinical trials within a month 8)Those who has been determined to be inappropriate of the study |
|||
| Target sample size | 15 | |||
| Research contact person | |
| Name of lead principal investigator | Saori Fujisaki |
| Organization | NIPPON FLOUR MILLS CO.,LTD. |
| Division name | Innovation center |
| Address | 5-1-3 Midorigaoka, Atsugi, Kanagawa, Japan |
| TEL | 046-222-6963 |
| s-fujisaki@nippn.co.jp | |
| Public contact | |
| Name of contact person | Mayumi Yamada |
| Organization | imeQ Co.Ltd. |
| Division name | DM |
| Address | 2-14-6 nishiwaseda shinjyu-city, Tokyo |
| TEL | 03-6205-6222 |
| Homepage URL | |
| m-yamada@imeq.co.jp | |
| Sponsor | |
| Institute | NIPPON FLOUR MILLS CO.,LTD. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | NIPPON FLOUR MILLS CO.,LTD. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 医療法人社団 札幌百合の会病院
SAPPORO YURINOKAI HOSPITAL |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032645 |